These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32580766)

  • 41. [Contraceptive implants--aberrations from insertion and removal procedures].
    Jørgensen NP
    Tidsskr Nor Laegeforen; 2010 Apr; 130(7):733-4. PubMed ID: 20379334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence of patients' challenges and barriers related to usage of Implanon®: scoping review protocol.
    Prosad S; Mashamba-Thompson TP; Ojewole E
    Syst Rev; 2018 Oct; 7(1):157. PubMed ID: 30309380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early Implanon discontinuation rate and its associated factors in health institutions of Mekelle City, Tigray, Ethiopia 2016/17.
    G/Medhin T; Gebrekidan KG; Nerea MK; Gerezgiher H; Haftu M
    BMC Res Notes; 2019 Jan; 12(1):8. PubMed ID: 30616681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients' perspectives about why they have their contraceptive Implanon NXT device removed early.
    Flore M; Chen XL; Bonney A; Mullan J; Dijkmans-Hadley B; Hodgkins A; Evans G; Frew H; Lloyd G
    Aust Fam Physician; 2016 Oct; 45(10):740-744. PubMed ID: 27695725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group.
    Bitzer J; Tschudin S; Alder J;
    Eur J Contracept Reprod Health Care; 2004 Dec; 9(4):278-84. PubMed ID: 15799185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Actual cost of providing long-acting reversible contraception: a study of Implanon cost.
    Lipetz C; Phillips C; Fleming C
    J Fam Plann Reprod Health Care; 2009 Apr; 35(2):75-9. PubMed ID: 19356275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early implanon discontinuation and associated factors among women ever used implanon in Mettu district, Oromia regional state, southwest Ethiopia, 2021.
    Tesfaye H; Negara E; Bayisa K
    Reprod Health; 2021 Aug; 18(1):176. PubMed ID: 34454512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group.
    Croxatto HB; Urbancsek J; Massai R; Coelingh Bennink H; van Beek A
    Hum Reprod; 1999 Apr; 14(4):976-81. PubMed ID: 10221230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences in family planning outcomes between military and general populations in Kinshasa, Democratic Republic of the Congo: a cross-sectional analysis.
    Akilimali P; Anglewicz P; Engale HN; Kurhenga GK; Hernandez J; Kayembe P; Bertrand J
    BMJ Open; 2018 Dec; 8(12):e022295. PubMed ID: 30580261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uptake and early removals of Implanon NXT in South Africa: Perceptions and attitudes of healthcare workers.
    Adeagbo O; Mullick S; Pillay D; Chersich M; Morroni C; Naidoo N; Pleaner M; Rees H
    S Afr Med J; 2017 Oct; 107(10):822-826. PubMed ID: 29397681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Family Planning in the Democratic Republic of the Congo: Encouraging Momentum, Formidable Challenges.
    Kwete D; Binanga A; Mukaba T; Nemuandjare T; Mbadu MF; Kyungu MT; Sutton P; Bertrand JT
    Glob Health Sci Pract; 2018 Mar; 6(1):40-54. PubMed ID: 29602865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo.
    Casey SE; Cannon A; Mushagalusa Balikubirhi B; Muyisa JB; Amsalu R; Tsolka M
    PLoS One; 2017; 12(9):e0182744. PubMed ID: 28886016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Continuation rates of the subdermal contraceptive Implanon(®) and associated influencing factors.
    Teunissen AM; Grimm B; Roumen FJ
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):15-21. PubMed ID: 24329119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics and experiences of American women electing for early removal of contraceptive implants.
    Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
    Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insertion and removal of Implanon: practical considerations.
    Mascarenhas L
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing the acceptability of Norplant contraceptive in four patient populations.
    Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
    Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contraceptive implants.
    McDonald-Mosley R; Burke AE
    Semin Reprod Med; 2010 Mar; 28(2):110-7. PubMed ID: 20352560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.